Follow-The-Filings

Security

Abcellera Biologics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

7 owners 1 new 2 exits max 0.0% (Two Sigma Investments, LP)

owners 7
max % 0.0%
tracked value $40M
qoq N 1 A 1 R 3 E 2

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.03 pp 5,810,985 $20M hist
Renaissance Technologies LLC 2026 Q1 0.0% Reduce 0.00 pp 1,510,629 $5M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Add 0.00 pp 1,149,325 $4M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 1,361,105 $5M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 1,294,574 $5M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% New 0.0% 359,683 $1M hist
Norges Bank 2025 Q4 stale 0.0% Exit 0.00 pp 176,386 $603 hist
Polen Capital Management LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 102,508 $351 hist
D. E. Shaw & Co., Inc. exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 77,776 $266 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $38.02M $28.83M $75.13M
Gross profit
Gross margin
Net income -$146.4M -$162.86M -$146.41M
Net margin * -385.0% -564.8% -194.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $871.98M $751.37M $728.23M
Total non-current assets $616.11M $609.18M $628.72M
Total assets $1.49B $1.36B $1.36B
Total current liabilities $119.01M $76.61M $64.31M
Total non-current liabilities $216.76M $227.86M $325.74M
Total equity $1.15B $1.06B $966.9M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$43.88M -$108.56M -$131.3M
Cash from investing -$221.11M $121.41M $87.75M
Cash from financing $10.36M $12.77M $14.08M
Net change in cash -$254.04M $23M -$28.37M

ownership over time

filing count by report period · click a bar for that quarter’s holders